magnevist 0.5mmol/ml solution for injection 10ml pre-filled syringes
bayer plc - meglumine gadopentetate - solution for injection - .5mmol/1ml
magnevist 0.5mmol/ml solution for injection 10ml vials
bayer plc - meglumine gadopentetate - solution for injection - .5mmol/1ml
magnevist 0.5mmol/ml solution for injection 15ml pre-filled syringes
bayer plc - meglumine gadopentetate - solution for injection - .5mmol/1ml
magnevist 0.5mmol/ml solution for injection 15ml vials
bayer plc - meglumine gadopentetate - solution for injection - .5mmol/1ml
magnevist 0.5mmol/ml solution for injection 20ml pre-filled syringes
bayer plc - meglumine gadopentetate - solution for injection - .5mmol/1ml
magnevist 0.5mmol/ml solution for injection 20ml vials
bayer plc - meglumine gadopentetate - solution for injection - .5mmol/1ml
magnevist 0.5mmol/ml solution for injection 5ml vials
bayer plc - meglumine gadopentetate - solution for injection - .5mmol/1ml
gadovist 1.0 gadobutrol 1.2094 g/2 ml solution for injection vial
bayer australia ltd - gadobutrol, quantity: 604.72 mg/ml - injection, solution - excipient ingredients: calcobutrol sodium; trometamol; hydrochloric acid; water for injections - this medicinal product is for diagnostic use only. gadovist 1.0 is indicated in adults and children including full-term newborns for: ? contrast enhancement in cranial and spinal magnetic resonance imaging (mri) ? contrast enhancement in whole body mri including head and neck region, thoracic space, breast, abdomen (pancreas, liver and spleen), pelvis (prostate, bladder and uterus), retroperitoneal space (kidney), extremities and musculoskeletal system ? use in first?pass mri studies of cerebral perfusion (see precautions) ? contrast enhancement in magnetic resonance angiography (ce mra) (see clinical trials) ? contrast enhancement in cardiac mri including assessment of rest and pharmacological stress perfusion and delayed enhancement
multihance gadobenate dimeglumine 10.58g/20ml solution for injection vial
bracco pty ltd - gadobenate dimeglumine, quantity: 529 mg/ml - injection, solution - excipient ingredients: water for injections - multihance is a paramagnetic contrast agent for use in diagnostic magnetic resonance imaging (mri) indicated for: for use in adults for the enhancement of magnetic resonance imaging (mri) of the liver and central nervous system (cns) for diagnostic use only. for use in adult patients with suspected or known vascular disease for contrast-enhanced magnetic resonance angiography of the abdominal or peripheral arteries where it improves the diagnostic accuracy for detecting clinically significant steno-occlusive vascular disease.
multihance gadobenate dimeglumine 5.29g/10ml solution for injection vial
bracco pty ltd - gadobenate dimeglumine, quantity: 529 mg/ml - injection, solution - excipient ingredients: water for injections - multihance is a paramagnetic contrast agent for use in diagnostic magnetic resonance imaging (mri) indicated for: for use in adults for the enhancement of magnetic resonance imaging (mri) of the liver and central nervous system (cns) for diagnostic use only. for use in adult patients with suspected or known vascular disease for contrast-enhanced magnetic resonance angiography of the abdominal or peripheral arteries where it improves the diagnostic accuracy for detecting clinically significant steno-occlusive vascular disease.